Urticasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-05-20
Share capital
21 000 000,00 PLN
Registered address
Krzemieniecka 120, 54-613 Wrocław, Poland
Electronic delivery address
AE:PL-16130-43627-JAUIU-29

Financials

Revenue history (in m)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.28bnMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD 40.57mMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 1.21bnMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 531.41mMedianUSD 539.29kAverageUSD 10.66m

Bank accounts

Registered as a VAT taxpayer on 1999-11-22. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

5 public aid cases recorded, with a total value of $16,870.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$5,052
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$3,726
Other crisis aid
$6,056

Tenders

6807 tenders recorded as contractor: 1895 national ($109,354,669) and 4912 EU ($20,673,920,362).

SubjectAmount
Zakup i sukcesywna dostawa leków onkologicznych oraz leków różnych.
—
Dostawa produktów leczniczych różnych dla SPZOZ w Sanoku
—
Zakup i sukcesywna dostawa leków onkologicznych oraz leków różnych.
—

Authorized Representatives

Katarzyna Patyńska Pniaczek — Vice President of the Management Board
Tibor Bartoszewicz — Vice President of the Management Board
Renata Mirosława Biel — President of the Management Board
Justyna Międzybrodzka — Attorney-in-fact (joint)

Manner of representation

In the event that a multi-member management board is appointed, joint action by two members of the management board or by a member of the management board jointly with a commercial proxy is required for the validity of declarations submitted on behalf of the company.

Supervisory board

Mariola Belina Prażmowska — Supervisory Board Member
Jacek Dauenhauer — Supervisory Board Member
Ignacy Przystalski — Supervisory Board Member
Zbigniew Molenda — Supervisory Board Member

Ownership

OwnerSharesShare valueStake
42,000$5,672,609.40100%

Beneficial owners

Person
Zbigniew Jacek Molenda (63)
Jacek Szwajcowski (62)

Subsidiaries

NameStake
LideoS.A.
100%
Pharmalinksp. z o.o.
50%

Change history

DateEvent
2024-07-23Share capital change
2018-03-27Name change
2002-05-20Entered in the register

FAQ

Last updated: 2026-07-17